Keep the route beside the result.
A cream, a spray and an injection can share an ingredient name without sharing the same evidence. Here’s a way to read a claim without chasing every technical detail: keep four things in view.
1. What exactly was used?
Look beyond the peptide name to the whole preparation. That’s what formulation means: the ingredient plus the cream, liquid or other materials carrying it. Two labels can name GHK-Cu while describing different products.
The review of topical GHK research explains why this matters. Getting the ingredient past skin’s outer barrier is a challenge. A study of one delivery system doesn’t settle what another cream can do.
The useful detail isn’t always the impressive-sounding ingredient. Sometimes it’s the rest of the bottle.
2. Where did it go?
Putting a serum on skin describes an application. Showing that its peptide got past the outer barrier takes a measurement. Those are separate steps, and neither one by itself tells us whether the product helped.
In the human skin experiment with copper peptide, researchers measured copper passing through pieces of skin in a lab. That’s useful work. It didn’t show that the whole GHK-Cu molecule crossed intact, or that a face cream reduced wrinkles in a person.
“Applied,” “absorbed” and “helped” aren’t three ways of saying the same thing. Each adds a claim that needs its own support.
3. Who, or what, was studied?
Cells in a dish, pieces of skin and people using a cream answer different questions. Even studies in people need context. Skin just treated with a laser isn’t the same setting as everyday skincare.
Our GHK-Cu page follows those differences through the studies. The semaglutide page shows why evidence for a finished tablet or injection doesn’t prove a topical claim. And the nasal-spray page keeps injection findings from being borrowed for the nose.
A quick check is often enough: does the study describe the product, route and kind of user the claim is talking about?
4. What changed, and what risks remain?
Copper reaching skin is a delivery result. Fewer wrinkles would be a cosmetic result. A person liking a cream is another kind of result again. None has to be dismissed; each needs its proper name.
Safety follows the route, too. For injectable GHK-Cu, FDA warns of possible immune reactions related to clumping and impurities. A history of using creams doesn’t answer that concern.
The rules also differ. Cosmetic claims and drug claims depend on the product’s intended use. And compounded medicines aren’t FDA-approved: FDA doesn’t check their safety, effectiveness or quality before marketing. A prescription doesn’t change that distinction.